Study suggests autophagy is involved in the onset of vascular dementia

Autophagy is a basic catabolic mechanism by which unnecessary or dysfunctional cellular components are degraded by lysosomes.

Damaged organelles such as mitochondria are scavenged by autophagic processes to maintain the stability of nerve cells. Excessive activation of autophagy leads to cell death. However, it remains unclear whether autophagy affects hippocampal neuronal injury in vascular dementia.

Prof. Bin Liu and co-workers from the Affiliated Hospital of Hebei United University, China intraperitoneally injected wortmannin into a rat model of vascular dementia. They found that wortmannin could inhibit hippocampal CA1 neuronal injury, elevate expression of the autophagy-related proteins beclin-1, cathepsin B and microtubule-associated protein 1 light chain 3. These results confirmed that autophagy is activated in the hippocampus of vascular dementia model rats, suggesting its involvement in the onset of vascular dementia, and that inhibition of autophagy has neuroprotective effects, indicating a novel pathway and target for drug treatment of vascular dementia. The relevant study has been published in the Neural Regeneration Research (Vol. 9, No. 13, 2014).

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Spermidine regulates RIPK1 to combat diabetes and vascular damage